TY - JOUR
T1 - The intravenous insulin tolerance test in Type I diabetes
AU - Lucas, K. J.
AU - Karounos, D. G.
AU - Ellis, G. J.
AU - Morris, M. A.
AU - Pisetsky, D. S.
AU - Feinglos, M. N.
PY - 1986
Y1 - 1986
N2 - The intravenous insulin tolerance test (ITT) allows general assessment of insulin sensitivity by determining the fall in plasma glucose after injection of 0.1 unit/kg regular insulin. To evaluate the usefulness of this test diagnostically in distinguishing Type I from Type II diabetes, 24 patients with Type I diabetes (defined as early age of onset, ideal body weight or less at onset, and insulin dependence) underwent ITTs. Seven patients had normal glucose disposal rates (K(i) ≥2.5. Nine patients had K(i) <2.5 but >1.0. Eight patients had K(i) <1.0. The slopes did not correlate with the control of the diabetes (as assessed by measurement of glycosylated hemoglobin), the presence or titer of anti-insulin antibodies, the duration of the diabetes, the age of onset, the presence of complications, or the current insulin dose. These results indicate that varying amounts of insulin resistance may be present in Type I diabetes and cannot necessarily be explained by poor control or the presence of insulin antibodies.
AB - The intravenous insulin tolerance test (ITT) allows general assessment of insulin sensitivity by determining the fall in plasma glucose after injection of 0.1 unit/kg regular insulin. To evaluate the usefulness of this test diagnostically in distinguishing Type I from Type II diabetes, 24 patients with Type I diabetes (defined as early age of onset, ideal body weight or less at onset, and insulin dependence) underwent ITTs. Seven patients had normal glucose disposal rates (K(i) ≥2.5. Nine patients had K(i) <2.5 but >1.0. Eight patients had K(i) <1.0. The slopes did not correlate with the control of the diabetes (as assessed by measurement of glycosylated hemoglobin), the presence or titer of anti-insulin antibodies, the duration of the diabetes, the age of onset, the presence of complications, or the current insulin dose. These results indicate that varying amounts of insulin resistance may be present in Type I diabetes and cannot necessarily be explained by poor control or the presence of insulin antibodies.
UR - http://www.scopus.com/inward/record.url?scp=0022552665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022552665&partnerID=8YFLogxK
M3 - Article
C2 - 3534980
AN - SCOPUS:0022552665
SN - 0034-5164
VL - 53
SP - 331
EP - 345
JO - Research Communications in Chemical Pathology and Pharmacology
JF - Research Communications in Chemical Pathology and Pharmacology
IS - 3
ER -